ASCL1 and neoplasm: On univariate analyses, longer overall survival was also associated with older age (> 3 years) and positive ASCL1 staining, but not OLIG2 or GFAP staining, tumor location, gross total resection or the presence of pathogenic/likely pathogenic SMARCB1 germline variants (Table 1).